Notice d.o.o. (Notice Slovenia) becomes Applus+ Laboratories’ second Notified Body under the EU Medical Device Regulation (MDR 2017/745)

This achievement comes just a few months after the acquisition of Notice Turkey in July 2025, which included its Slovenian subsidiary, Notice d.o.o. Notice Turkey has been a designated Notified Body since 2023, and now, with Notice Slovenia obtaining its own designation, Applus+ Laboratories can count two Notified Bodies under MDR, a significant accomplishment given that there are only 51 Notified Bodies worldwide under this regulation. 

The EU Medical Device Regulation (MDR 2017/745) sets strict requirements for the design, testing, manufacturing, and post-market surveillance of medical devices in Europe, ensuring the highest standards of patient safety and product performance. Being designated as an MDR Notified Body is a mark of excellence, demonstrating the capability to independently assess and certify medical devices in full compliance with these rigorous regulations. 

With the acquisition of Notice, Applus+ Laboratories became a one-stop-shop for medical device testing and certification, offering manufacturers comprehensive support across the full spectrum of regulatory compliance. This new designation marks another important milestone for our group, expanding our capabilities in the medical device sector and strengthening our presence within the European regulatory landscape. 

With now two MDR-designated Notified Bodies, Applus+ Laboratories reinforces its commitment to supporting medical device manufacturers across Europe and beyond in achieving compliance and ensuring the highest levels of patient safety. This milestone also demonstrates Applus+ Laboratories’ medical device testing services expertise, which ranges from cybersecurity for medical devices, biocompatibility testing, and other critical assessments, further strengthening its position as a trusted partner for medical device conformity assessment and expanding its global network of technical experts and regulatory capabilities. 

About the Applus+ Group 

Applus+ is one of the world’s leading companies in the testing, inspection, and certification sector. We are a trusted partner that helps clients enhance the quality and safety of their assets and operations while safeguarding their environmental performance. Our technical capability, innovation, and highly qualified team of more than 28,000 professionals allow us to ensure operational excellence across a wide range of sectors in over 65 countries. 

We offer a comprehensive portfolio of solutions to meet a variety of needs, from asset management to regulatory inspections. At Applus+, we maintain a strong commitment to technological development, digitalisation, and the constant updating of our knowledge of standards and regulatory requirements. 

About Applus+ Laboratories 

Applus+ Laboratories is a division of the Applus+ Group, dedicated to providing testing and certification services to enhance the competitiveness of our clients' products and foster innovation. 

We are headquartered in Barcelona, Spain, and our expanding network of multidisciplinary laboratories around the world plays a crucial role in advancing the industries we serve, including aerospace, automotive, cybersecurity, electrical and electronics, renewable energies, construction, railway, and medical devices. 

Our state-of-the-art facilities, deep expertise, and advanced capabilities allow us to collaborate with leading technological corporations globally. We are eager to partner with you to help meet your market needs and drive your success.